AVITA Medical

#News: AVITA Medical ($RCEL, $AVH) receives CE Mark for RECELL® GO, enabling commercialization across Europe. Press Release: ir.avitamedical.com/press-releases…..

Please join us today, Monday, September 8, at 4:05 p.m. EST, for a fireside chat with Jim Corbett, our chief executive officer, at the Morgan Stanley 23rd Annual Global Healthcare Conference. You can listen to the webcast live or later on demand at: ir.avitamedical.com/events/event-d…

36% shorter hospital stays. Data presented at #EBA2025 reinforces that RECELL® leads to significantly reduced length of stay vs. traditional grafting. Fewer days in hospital = lower costs, faster recovery, greater system efficiency. ir.avitamedical.com/press-releases….. #MedTech #Healthcare

Our CEO Jim Corbett joined On the Couch to share our mission and what’s ahead for AVITA Medical. Key themes: ✅Innovation in acute wound care ✅Growth drivers in the next 12 months ✅Why “36” is our rallying number 🎧 Hear the full conversation: marcustodayonthecouch.buzzsprout.com/1852332/episod…

"Not only was the healing time so much faster, but the way that I look today is because of RECELL." Tiara Bowers suffered severe burns from an explosive house fire. Her doctor recommended RECELL® to expedite healing at the cellular level. Watch her story: hubs.ly/Q03DSWGT0

Rich Raymond, RN, presented a case study during the recent AVITA Medical Acute Wound Care Showcase. The study featured outcomes of a pediatric burn treated with PermeaDerm®. Watch as he shares the story of his patient's healing journey. hubs.ly/Q03Dm-Xx0

Katie Bush, PhD, Senior Vice President of Scientific and Medical Affairs at AVITA Medical, shares how RECELL® is evolving and what its expanding role could mean for plastic and reconstructive surgery in a recent Plastic Surgery Practice interview. hubs.ly/Q03D8CBk0

Katie Bush, Senior Vice President of Scientific and Medical Affairs, was recently interviewed by Plastic Surgery Practice (PSP) about RECELL Spray-On Skin™ Cells for acute wound care. Read it here: hubs.ly/Q03C7P8n0

#NEWS We’ve successfully completed an equity placement on the ASX, securing approximately US$15 million (~A$23 million) to support our continued growth. You can read our press release for the full details: ir.avitamedical.com/press-releases… $RCEL $AVH

View a case study in which PermeaDerm® was applied to a surgical wound prior to autografting. The surgical team opted for PermeaDerm over an allograft due to its cost-effectiveness, flexibility, and transparency. hubs.ly/Q03BmjtX0

Healthcare professional education is one of our top priorities. If your team would like to participate in a cadaver lab or hands-on learning workshop about our acute wound care solutions, reach out to your local sales representative.

PermeaDerm® biosynthetic wound matrix is a next-generation surgical dressing with multiple features that benefit clinicians, patients, and facilities. Clinicians adopt it into their standard of care for its ease of use, single application, and customizable moisture management.

In a recent clinical case series describing the first patient use, Cohealyx™ demonstrated wound bed readiness in as little as five to ten days. Read more on this clinical case: hubs.ly/Q03y3GvD0

A peer-reviewed, head-to-head pre-clinical study demonstrated favorable performance by Cohealyx™ collagen dermal matrix across key outcomes. See how Cohealyx stands out: hubs.ly/Q03y3z020

When it's time to graft, it's time to consider RECELL® Spray-On Skin™ Cells. RECELL technology accelerates healing at the cellular level and reduces donor skin requirements.

Join us from July 22-23, 2025 at IDGA’s VA Healthcare conference in Arlington, VA along with 500+ senior leaders, clinicians, nurses, administrators, and technology professionals from across the veterans' healthcare sector. #VAhealthcare #Veterans

Sharon Grason, PhD, RN, writes about the importance of reducing wound healing time using a two-stage approach in her latest article on enhancing traumatic wound management. Read the full article here: hubs.ly/Q03xt3JK0

International healthcare professionals are invited to attend a webinar with Anjay Khandelwal, MD, FACS, FICS, as he discusses RECELL Spray-On Skin™ Cells for pediatric and vulnerable populations. Register: hubs.ly/Q03x6R5T0 Content is approved for International use only.

The future of acute wound care is here! View a clinical case of a 440cm2 full-thickness wound resulting from surgical excision. Cohealyx™ collagen dermal matrix was applied, followed by meshed autograft and RECELL® Spray-On Skin™ Cells. hubs.ly/Q03x5w120

AVITA Medical participated in the recent Plastic Surgery Congress in Sydney, Australia. Winthrop Professor Fiona Wood, FRCS, FRACS, AM, an inventor of RECELL Spray-On Skin™ Cells, delivered an educational lecture on the use of cell-based therapies in skin repair.